Adam Scott Levy insider trades

Open-market stock purchases and sales by Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc, from SEC Form 4 filings since Feb 16, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +62%.

Recent trades

DateStockTradeValue
Feb 19, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Feb 19, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jan 12, 2026MLYS Mineralys Therapeutics, IncSold$346K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$42.6K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$473K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$66.6K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$1.5M
Nov 11, 2025MLYS Mineralys Therapeutics, IncBought (not open market)—
Nov 11, 2025MLYS Mineralys Therapeutics, IncBought (not open market)—
Nov 11, 2025MLYS Mineralys Therapeutics, IncBought (not open market)—
Nov 11, 2025MLYS Mineralys Therapeutics, IncBought (not open market)—
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$539K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$359K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$180K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$382K
Nov 11, 2025MLYS Mineralys Therapeutics, IncSold$1.8M
Oct 13, 2025MLYS Mineralys Therapeutics, IncSold$309K
Oct 13, 2025MLYS Mineralys Therapeutics, IncSold$143K

Companies traded

  • MLYS Mineralys Therapeutics, Inc: 1 buy, 23 sales, last Feb 19, 2026
  • BBI Brickell Biotech, Inc: other filings, last Mar 16, 2020
  • MGEN Miragen Therapeutics, Inc: 2 buys, last Feb 13, 2018

Get free alerts when Adam Scott Levy files a new trade →